Does Rallies show 13F holders for STOK?

Yes. Rallies tracks hedge fund and 13F ownership data for STOK, including fund names, share counts, latest tracked quarter, and position changes when available.

Is STOK research on Rallies investment advice?

No. Rallies provides research, data, and educational context for STOK. It does not provide personalized investment advice.

STOK (Stoke Therapeutics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Stoke Therapeutics, Inc. Common Stock (STOK) is a publicly traded Healthcare sector company. As of May 21, 2026, STOK trades at $30.76 with a market cap of $1.81B and a P/E ratio of -10.54. STOK moved +1.13% today. Year to date, STOK is -6.93%; over the trailing twelve months it is +201.44%. Its 52-week range spans $5.35 to $40.22. Analyst consensus is strong buy with an average price target of $46.71. Rallies surfaces STOK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns STOK stock?

Hedge funds tracked by Rallies that own STOK include Redmile Group, Panagora Asset, and Farallon Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Stoke Therapeutics, Inc. Common Stock.

STOK Key Metrics

Key financial metrics for STOK
Metric	Value
Price	$30.76
Market Cap	$1.81B
P/E Ratio	-10.54
EPS	$-2.84
Dividend Yield	0.00%
52-Week High	$40.22
52-Week Low	$5.35
Volume	506.93K
Avg Volume	0
Revenue (TTM)	$32.08M
Net Income	$-169.77M
Gross Margin	0.00%

Top Hedge Funds Holding STOK

Redmile Group holds 4.16M shares of STOK, changed +3.22% as of Mar 31, 2026.
Panagora Asset holds 104.27K shares of STOK, changed +0.00% as of Dec 31, 2024.
Farallon Capital holds 9.00K shares of STOK, changed +0.00% as of Mar 31, 2026.

Recent STOK Insider Trades

Ticho Barry sold 2.24K (~$73.55K) on May 1, 2026.
Ticho Barry sold 1.84K (~$60.03K) on Apr 1, 2026.
Allan Jonathan sold 8.69K (~$292.36K) on Mar 20, 2026.

STOK Analyst Consensus

8 analysts cover STOK: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $46.71.

Common questions about STOK

Who owns STOK stock?: Hedge funds tracked by Rallies that own STOK include Redmile Group, Panagora Asset, and Farallon Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Stoke Therapeutics, Inc. Common Stock.
Does Rallies show 13F holders for STOK?: Yes. Rallies tracks hedge fund and 13F ownership data for STOK, including fund names, share counts, latest tracked quarter, and position changes when available.
Is STOK research on Rallies investment advice?: No. Rallies provides research, data, and educational context for STOK. It does not provide personalized investment advice.